1-5 of 5
Ulf Tidefelt
Close
Sort by
Journal Articles

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks

Stefan Deneberg, Philippe Guardiola, Andreas Lennartsson, Ying Qu, Verena Gaidzik, Odile Blanchet, Mohsen Karimi, Sofia Bengtzén, Hareth Nahi, Bertil Uggla, Ulf Tidefelt, Martin Höglund, Christer Paul, Karl Ekwall, Konstanze Döhner, Sören Lehmann
Journal: Blood
Blood (2011) 118 (20): 5573–5582.
https://doi.org/10.1182/blood-2011-01-332353
Published: 2011
Includes: Supplemental data
Journal Articles

Global and HOX Gene DNA Methylation In Normal Karyotype Acute Myeloid Leukemia: Clinical Implications and Molecular Correlations

Stefan Deneberg, MD, Andreas Lennartsson, PhD, Bertil Uggla, MD, PhD, Verena Gaidzik, Andrea Corbacioglu, PhD, Hareth Nahi, MD, PhD, Konstanze Dohner, MD, PhD, Karl Ekwall, MD, PhD, Ulf Tidefelt, MD, PhD, Martin Hoglund, MD, PhD, Sören Lehmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 231.
https://doi.org/10.1182/blood.V116.21.231.231
Published: 2010
Journal Articles

Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.

Gunnar Juliusson, Lars Möllgård, Sören Lehmann, MD, PhD, Åsa Rangert Derolf, M.D., Ulf Tidefelt, MD, PhD, Dick Stockelberg, MD, PhD, Mats L Brune, Vladimir Lazarevic, Petar Antunovic, Anders Wahlin, Martin Hoglund, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2289.
https://doi.org/10.1182/blood.V114.22.2289.2289
Published: 2009
Journal Articles

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Clinical Trials & Observations
Gunnar Juliusson, Petar Antunovic, Åsa Derolf, Sören Lehmann, Lars Möllgård, Dick Stockelberg, Ulf Tidefelt, Anders Wahlin, Martin Höglund
Journal: Blood
Blood (2009) 113 (18): 4179–4187.
https://doi.org/10.1182/blood-2008-07-172007
Published: 2009
Journal Articles

Individualized Tumor Response (ITR) Profiling for Drug Selection in Tailored Therapy: Meta-Analysis of 1929 Cases of Leukemia and Lymphoma.

Andrew G. Bosanquet, PhD, MRCPath, Gertjan J. Kaspers, MD, PhD, Rolf Larsson, MD, Robert A. Nagourney, MD, PhD, Peter Nygren, MD, PhD, Rob Pieters, MD, PhD, Peter Staib, MD, Ulf Tidefelt, MD, PhD, C. Michel Zwaan, MD, PhD, Larry M. Weisenthal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 3471.
https://doi.org/10.1182/blood.V110.11.3471.3471
Published: 2007